Patrick Shahgaldian PhD
Wednesday 3rd July 2024, 11:00-12:00
In Silica Enzymes Nano-engineering towards Nanobiotechnology and Nanomedicine
Patrick Shahgaldian is a professor of Molecular Nanotechnology at the University of Applied Sciences Northwestern Switzerland (FHNW). He studied biochemistry at the University of Lyon and obtained a PhD in supramolecular chemistry working with Prof. Tony Coleman at the Institute of Biology and Chemistry of Proteins. He worked on the design of amphiphilic macrocyclic molecules (i.e., calixarenes, cyclodextrins) and their ability to self-assemble at interfaces and in water. After a postdoctoral stay at the Institute of Physics of the University of Basel, he moved to FHNW where he was appointed professor. His group focuses on designing functional nanomaterials with molecular recognition or (bio)catalytic properties. In addition, two biotech companies were spun off from his research activities, namely INOFEA and Perseo Pharma. He is currently a member of the board of directors of both companies. In addition to coauthoring over 100 research manuscripts, he has co-invented over 12 patents.
Visit us on Social Media
#ECB2024
Please note: All information requested on the website and registration process is strictly for the use of the Congress in compliance with international privacy legislation. By completing this registration form you will agree that the Congress will use this data to keep you fully informed of the Congress in 2024. The data will then be retained by the Congress secretariat for the purposes of informing you about activities and future meetings. On the registration form, You will also have the opportunity to agree separately to allow key data (Name, Company, Email Address) to be shared with sponsors and exhibitors who are participating in the Congress in 2024. We will not pass any details to any companies not participating in the Congress in 2024.